Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

1.83
-0.0350-1.88%
Volume:697.32K
Turnover:1.29M
Market Cap:68.30M
PE:-1.24
High:1.91
Open:1.86
Low:1.80
Close:1.86
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:1.56
T/O Rate:3.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.60
PE(LYR):-1.36

Loading ...

Tenax Therapeutics highlights key Phase 3 LEVEL trial

TIPRANKS
·
Jul 02

Tenax Therapeutics Flags Announcement on LEVEL Trial Data Presentation at ESC Congress 2026

Reuters
·
Jul 02

Tenax Therapeutics Announces Late-breaking Presentation of Level Clinical Trial Data at Esc Congress 2026

THOMSON REUTERS
·
Jul 02

Tenax Therapeutics: Extends US Regulatory Approval Deadline to December 31, 2035 Via Sixth Amendment to Orion License - SEC Filing

THOMSON REUTERS
·
Jul 01

Tenax Signs Oral Levosimendan Supply Deal with Orion

Reuters
·
Jul 01

Tenax Therapeutics Updates Executive and Employee Severance Protections

TIPRANKS
·
Jun 30

Tenax Therapeutics Amends Executive Employment Agreements to Expand Severance, Change-in-control Benefits

Reuters
·
Jun 30

Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Biohaven Ltd. (BHVN) and BioLife Solutions (BLFS)

TIPRANKS
·
Jun 25

Tenax Therapeutics Price Target Maintained with a $35.00/share by Cantor Fitzgerald

Dow Jones
·
Jun 24

Tenax Therapeutics Initiated at Buy by Chardan Capital

Dow Jones
·
Jun 22

Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Abbott Laboratories (ABT) and AbbVie (ABBV)

TIPRANKS
·
Jun 22

Tenax Therapeutics price target raised to $40 from $34 at Guggenheim

TIPRANKS
·
Jun 22

Chardan Initiates Tenax Therapeutics at Buy

MT Newswires Live
·
Jun 22

Tenax Therapeutics initiated with a Buy at Chardan

TIPRANKS
·
Jun 22

Tenax Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Jun 13

Tenax Therapeutics price target raised to $50 from $20 at Piper Sandler

TIPRANKS
·
Jun 12

Tenax Therapeutics Announces Results of 2026 Annual Meeting

TIPRANKS
·
Jun 05

Tenax Therapeutics shareholders ratified Cherry Bekaert as independent auditor for 2026

Reuters
·
Jun 05

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Compass Therapeutics (CMPX) and Tenax Therapeutics (TENX)

TIPRANKS
·
Jun 01

LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)

TIPRANKS
·
May 16